Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
629.00    -31.00 (-4.70%)
Bid:
626.00
Ask:
628.00
Spread: 2.00 (0.319%)
Market Cap: £1.16b
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

Director/PDMR Shareholding

29 Jun 2022 17:08

RNS Number : 7060Q
Volex PLC
29 June 2022
 

29 June 2022

 

Volex plc

("Volex" or the "Company")

Director/PDMR Shareholding

The Company announces that Nat Rothschild, Executive Chairman, John Molloy, Group Chief Operating Officer, and Jon Boaden, Chief Financial Officer have been granted Deferred Bonus Awards under the Company's Deferred Share Bonus Plan 2015 as part of their remuneration in respect of the 2022 financial year. 

The following disclosure is made in accordance with Article 19 of the UK version of the EU Market Abuse Regulation 596/2014 which has effect in English law by virtue of the European Union (Withdrawal) Act 2018.

 

Notification of transactions by Directors / persons discharging managerial responsibilities and persons closely associated with them:

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

1. Nat Rothschild

2. John Molloy

3. Jon Boaden

 

2

Reason for the notification

a)

 

Position/status

 

1. Executive Chairman

2. Group Chief Operating Officer

3. Chief Financial Officer

 

b)

 

Initial notification /Amendment

 

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

Volex Plc

b)

 

LEI (inclusion optional)

 

213800HBLQNH5FXXGE63

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of 25 pence each

 

 

GB0009390070

b)

 

Nature of the transaction

 

 

Grant of Deferred Bonus Awards pursuant to the Volex Plc Deferred Bonus Plan 2015

c)

 

Price(s) and volume(s)

 

 

Prices(s)

Volume(s)

Exercise price of £0.00

1. 29,389 Ordinary Shares

2. 20,578 Ordinary Shares

3. 18,711 Ordinary Shares

 

d)

 

Aggregated information

- Aggregated volume

- Price

 

 

Price

Volume

Aggregate Price

1

£0.00

29,389

£0.00

2

£0.00

20,578

£0.00

3

£0.00

18,711

£0.00

 

 

e)

 

Date of the transaction

 

28 June 2022

f)

 

Place of the transaction

 

Outside a trading venue

 

For further information please contact:

Volex plc

+44 (0)7971 156 431

Nat Rothschild, Executive Chairman

Jon Boaden, Chief Financial Officer

Christian Bedford, Group General Counsel and Company Secretary

 

Singer Capital Markets - Nominated Adviser & Joint Broker

+44 (0)20 7496 3000

Shaun Dobson

George Tzimas

 

HSBC Bank plc - Joint Broker

+44 (0)20 7991 8888

Simon Alexander

Joe Weaving

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBLGDLRGDDGDC
Date   Source Headline
26th May 20263:00 pmRNSNotice of Results
15th May 20267:45 amRNSHolding(s) in Company
11th May 20267:00 amRNSHolding(s) in Company
30th Apr 20263:07 pmRNSHolding(s) in Company
22nd Apr 20267:00 amRNSCapital Markets Event
7th Apr 20267:00 amRNSLaunch of £40 million Share Buyback Programme
7th Apr 20267:00 amRNSUpdate on Move to the Main Market
26th Mar 20265:30 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSTrading update and Notice of Capital Markets Event
20th Mar 20262:00 pmRNSDirector/PDMR Shareholding
10th Feb 20267:45 amRNSHolding(s) in Company
2nd Feb 20264:45 pmRNSDirector/PDMR Shareholding
30th Jan 20264:30 pmRNSDirector/PDMR Shareholding
21st Jan 20267:00 amRNSTrading Update
12th Jan 20265:30 pmRNSDirector/PDMR Shareholding
8th Jan 20262:00 pmRNSDirector/PDMR Shareholding
5th Jan 20263:00 pmRNSIssue of Equity and Total Voting Rights
15th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 20255:55 pmRNSDirector/PDMR Shareholding
4th Dec 202511:30 amRNSScrip Reference Price
12th Nov 20257:00 amRNSAppointment of Non-Executive Chair and CEO
12th Nov 20257:00 amRNSHalf-year Report
20th Oct 20257:00 amRNSNotice of Results
16th Oct 20257:00 amRNSHalf Year Trading Update
29th Sep 20251:25 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSHolding(s) in Company
15th Sep 202511:30 amRNSDirector/PDMR Shareholding
15th Sep 202510:15 amRNSHolding(s) in Company
5th Sep 20259:00 amRNSDirector/PDMR Shareholding
1st Sep 20251:00 pmRNSIssue of Equity and Total Voting Rights
7th Aug 20254:35 pmRNSResult of AGM
7th Aug 202512:30 pmRNSScrip Reference Price
7th Aug 20257:00 amRNSAGM Statement
4th Aug 20252:00 pmRNSHolding(s) in Company
7th Jul 20254:35 pmRNSPDMR / PCA Shareholding
4th Jul 202511:00 amRNSNotice of AGM and Publication of Annual Report
26th Jun 20257:00 amRNSPreliminary Group Results FY2025
2nd Jun 20257:00 amRNSNotice of Results and Investor Presentation
16th Apr 20252:00 pmRNSDirector/PDMR Shareholding
16th Apr 20251:00 pmRNSDirector/PDMR Shareholding
10th Apr 20256:00 pmRNSDirector/PDMR Shareholding
7th Apr 20257:00 amRNSFull Year Trading Update
19th Mar 20253:30 pmRNSDirector/PDMR Shareholding
13th Mar 20255:45 pmRNSHolding(s) in Company
27th Jan 20257:00 amRNSChange of Adviser
27th Jan 20257:00 amRNSTrading Update
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
3rd Jan 20257:00 amRNSDeferred Consideration for Acquisition
19th Dec 20247:00 amRNSForm 8.3 - Volex PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.